Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$96.13+0.62 (+0.65%)
Close on Nov 20, 2026Market cap $6.24BP/E –Yield –
Mirum Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Mirum Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$228.74M, down 2751.5% year over year. For fiscal 2025 it was $54.87M, up 488.0% from the year before. The highest annual figure on record is $54.87M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.87M | +488.0% |
| FY2024 | Dec 31, 2024 | $9.33M | – |
| FY2023 | Dec 31, 2023 | -$71.05M | – |
| FY2022 | Dec 31, 2022 | -$120.41M | – |
| FY2021 | Dec 31, 2021 | -$132.78M | – |
| FY2020 | Dec 31, 2020 | -$89.30M | – |
| FY2019 | Dec 31, 2019 | -$39.64M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$44.28M | -471.6% |
| Q1 FY2026 | Mar 31, 2026 | -$229.43M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.47M | – |
| Q3 FY2025 | Sep 30, 2025 | $39.49M | +938.5% |
| Q2 FY2025 | Jun 30, 2025 | $11.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.00M | -113.2% |
| Q4 FY2024 | Dec 31, 2024 | -$5.09M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.58M | – |
| Q1 FY2024 | Mar 31, 2024 | $15.20M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.62M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.51M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.04M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$39.67M | – |
| Q4 FY2021 | Dec 31, 2021 | -$33.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$34.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$40.20M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.21M | – |
| Q4 FY2020 | Dec 31, 2020 | -$36.31M | – |
| Q3 FY2020 | Sep 30, 2020 | -$17.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$17.05M | – |
| Q1 FY2020 | Mar 31, 2020 | -$18.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.77M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.39M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.47M | – |
See a number that looks wrong?